Skip to main content

Table 8 Details of best-docked complexes of proteins with least energy and main hydrogen bond interaction showed amino acid residues on the binding sites

From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug

Protein name and drug name

Type of docking

Docking score

Binding energy (kcal/mol)

Complex energy (kcal/mol)

Interacting residues

Protein: 2WGJ

DRUG-TEMOZOLOMIDE

DIRECT(P4)

68.0813

− 27.8584

− 11,305.0830

PRO1158, MET1160

Protein: 3ZBF

DRUG-TEMOZOLOMIDE

PDB(P4)

58.5464

− 40.5732

− 11,659.6814

MET2029, GLU2027

Protein: 2XP2

DRUG-

TEMOZOLOMIDE

RC(S1,P2)

60.1738

− 44.4725

− 11,734.7565

ARG1275, ASP1160, GLU1167